Literature DB >> 16341839

The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes.

S Aiston1, L J Hampson, C Arden, P B Iynedjian, L Agius.   

Abstract

AIMS/HYPOTHESIS: An insulin signalling pathway leading from activation of protein kinase B (PKB, also known as Akt) to phosphorylation (inactivation) of glycogen synthase kinase-3 (GSK-3) and activation of glycogen synthase is well characterised. However, in hepatocytes, inactivation of GSK-3 is not the main mechanism by which insulin stimulates glycogen synthesis. We therefore tested whether activation of PKB causes inactivation of glycogen phosphorylase.
MATERIALS AND METHODS: We used a conditionally active form of PKB, produced using recombinant adenovirus, to test the role of acute PKB activation in the control of glycogen phosphorylase and glycogen synthesis in hepatocytes.
RESULTS: Conditional activation of PKB mimicked the inactivation of phosphorylase, the activation of glycogen synthase, and the stimulation of glycogen synthesis caused by insulin. In contrast, inhibition of GSK-3 caused activation of glycogen synthase but did not mimic the stimulation of glycogen synthesis by insulin. PKB activation and GSK-3 inhibition had additive effects on the activation of glycogen synthase, indicating convergent mechanisms downstream of PKB involving inactivation of either phosphorylase or GSK-3. Glycogen synthesis correlated inversely with the activity of phosphorylase-a, irrespective of whether this was modulated by insulin, by PKB activation or by a selective phosphorylase ligand, supporting an essential role for phosphorylase inactivation in the glycogenic action of insulin in hepatocytes. CONCLUSIONS/
INTERPRETATION: In hepatocytes, the acute activation of PKB, but not the inhibition of GSK-3, mimics the stimulation of glycogen synthesis by insulin. This is explained by a pathway downstream of PKB leading to inactivation of phosphorylase, activation of glycogen synthase, and stimulation of glycogen synthesis, independent of the GSK-3 pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341839     DOI: 10.1007/s00125-005-0068-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis.

Authors:  Susan Aiston; Matthew P Coghlan; Loranne Agius
Journal:  Eur J Biochem       Date:  2003-07

2.  The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase.

Authors:  F V Lali; A E Hunt; S J Turner; B M Foxwell
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin.

Authors:  S Aiston; L Agius
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

4.  Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner.

Authors:  Y Fujio; K Walsh
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

5.  Signalling pathways involved in the stimulation of glycogen synthesis by insulin in rat hepatocytes.

Authors:  M Peak; J J Rochford; A C Borthwick; S J Yeaman; L Agius
Journal:  Diabetologia       Date:  1998-01       Impact factor: 10.122

6.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 7.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

8.  Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions.

Authors:  Takashi Katome; Toshiyuki Obata; Rie Matsushima; Norihisa Masuyama; Lewis C Cantley; Yukiko Gotoh; Kazuhiro Kishi; Hiroshi Shiota; Yousuke Ebina
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

9.  Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1) mRNAs in hepatocytes.

Authors:  Pascale G Ribaux; Patrick B Iynedjian
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

10.  A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Authors:  Stella George; Justin J Rochford; Christian Wolfrum; Sarah L Gray; Sven Schinner; Jenny C Wilson; Maria A Soos; Peter R Murgatroyd; Rachel M Williams; Carlo L Acerini; David B Dunger; David Barford; A Margot Umpleby; Nicholas J Wareham; Huw Alban Davies; Alan J Schafer; Markus Stoffel; Stephen O'Rahilly; Inês Barroso
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

View more
  9 in total

1.  Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function.

Authors:  Klaas Romanino; Laetitia Mazelin; Verena Albert; Agnès Conjard-Duplany; Shuo Lin; C Florian Bentzinger; Christoph Handschin; Pere Puigserver; Francesco Zorzato; Laurent Schaeffer; Yann-Gaël Gangloff; Markus A Rüegg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

4.  Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3.

Authors:  Wen-Jing Liu; Lan-Qing Ma; Wei-Hua Liu; Wei Zhou; Ke-Qin Zhang; Cheng-Gang Zou
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

5.  Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.

Authors:  L J Hampson; P Mackin; L Agius
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

6.  Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Yuka Fujimoto; E P Donahue; Richard L Printz; Karen L Houseknecht; Judith L Treadway; Masakazu Shiota
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

Review 7.  Pancreatic regulation of glucose homeostasis.

Authors:  Pia V Röder; Bingbing Wu; Yixian Liu; Weiping Han
Journal:  Exp Mol Med       Date:  2016-03-11       Impact factor: 8.718

8.  Proteomic Analysis of 3T3-L1 Adipocytes Treated with Insulin and TNF-α.

Authors:  Hayley Chan; Ketaki P Bhide; Aditya Vaidyam; Victoria Hedrick; Tiago Jose Paschoal Sobreira; Thomas G Sors; Ryan W Grant; Uma K Aryal
Journal:  Proteomes       Date:  2019-10-20

9.  The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.

Authors:  Rei Noguchi; Hiroyuki Kubota; Katsuyuki Yugi; Yu Toyoshima; Yasunori Komori; Tomoyoshi Soga; Shinya Kuroda
Journal:  Mol Syst Biol       Date:  2013-05-14       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.